Detalles de la búsqueda
1.
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
J Med Chem;
48(15): 5025-37, 2005 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16033281
2.
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.
J Med Chem;
47(10): 2587-98, 2004 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-15115400
Resultados
1 -
2
de 2
1
Próxima >
>>